JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Imaging Surveillance After Breast-Conserving Surgery for Cancer With Acellular Dermal Matrix Reconstruction

  • 0Department of Radiology, Ewha Womans University Mokdong Hospital, Seoul, Republic of Korea.
Korean Journal of Radiology +

|

October 30, 2024

|

October 30, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

This study analyzed imaging findings after breast reconstruction with MegaDerm® (sheet-type and pellet-type) following breast-conserving surgery. Recognizing suspicious findings near MegaDerm® is crucial for distinguishing false positives from cancer recurrences.

Area Of Science

  • Oncology
  • Radiology
  • Plastic Surgery

Background

  • Breast-conserving surgery (BCS) for cancer often requires reconstruction.
  • MegaDerm® (sheet-type and pellet-type) is a dermal regeneration template used for immediate breast reconstruction post-BCS.
  • Differentiating postoperative imaging changes from malignancy is critical for patient management.

Purpose Of The Study

  • To investigate postoperative imaging findings in patients reconstructed with MegaDerm® after BCS.
  • To analyze the characteristics of false positives and recurrences in relation to MegaDerm®.
  • To evaluate multi-modality imaging findings (mammography, ultrasonography, MRI) for MegaDerm® implants.

Main Methods

  • Retrospective analysis of 201 women undergoing BCS and MegaDerm® reconstruction.
  • Review of 713 mammography (MG), 1063 ultrasonography (US), and 607 MRI examinations.
  • Analysis of suspicious findings, focusing on those in direct contact with MegaDerm®.

Main Results

  • MegaDerm® imaging characteristics varied by type (sheet vs. pellet) and modality.
  • Suspicious findings in direct contact with MegaDerm® were observed in 9/17 false positives and 6/9 recurrences.
  • Common suspicious findings included calcifications, irregularities, and masses, with specific patterns on MG, US, and MRI.

Conclusions

  • Suspicious imaging findings adjacent to MegaDerm® can indicate either false positives or recurrences.
  • Familiarity with MegaDerm®-associated imaging findings is essential for accurate interpretation.
  • Correlation with patient history and follow-up imaging is vital when evaluating suspicious findings.

Keywords: